acellular nerve allograft
Trade name: Avance
Biologicalapproved
Approved
Dec 3, 2025
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
2020s
- Dec 3, 2025
Earliest FDA Approval
Indications
Approved for
Mechanism of action
- Nerve cordTissue restoration
Nerve cord tissue restoration
Approval history
- approvedDec 3, 2025
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No